NCT04927572View on ClinicalTrials.gov

Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 13, 2021

Primary Completion Date

August 9, 2022

Study Completion Date

August 9, 2022

Conditions
Atopic Dermatitis
Interventions
DRUG

FMX114

Active Comparator

OTHER

Vehicle

Placebo Comparator

Trial Locations (7)

2010

Investigator #6, Darlinghurst

2606

Investigator #5, Phillip

5000

Investigational Site #1, Adelaide

18249

Investigator #13, Sugarloaf

33027

Investigator #12, Miramar

33173

Investigator #9, Miami

33175

Investigator #14, Miami

All Listed Sponsors
lead

Vyne Therapeutics Inc.

INDUSTRY

NCT04927572 - Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis | Biotech Hunter | Biotech Hunter